DCIS knowledge of women choosing between active surveillance and surgery for low-risk DCIS
Ellen G. Engelhardt(The Netherlands Cancer Institute), Lotte Elshof, Lodewyk F.A. Wessels(The Netherlands Cancer Institute), Jelle Wesseling(Leiden University Medical Center), Proteeti Bhattacharjee(The Netherlands Cancer Institute), Alastair M. Thompson(Baylor College of Medicine), Fariba Behbod(University of Kansas), Julia Houtzager(The Netherlands Cancer Institute), Daniel Rea(University Hospitals Birmingham NHS Foundation Trust), Miranda A. Gerritsma(The Netherlands Cancer Institute), Jacco van Rheenen(The Netherlands Cancer Institute), Ellen Verschuur(Borstkankervereniging Nederland), Jos Jonkers(The Netherlands Cancer Institute), Nicholas E. Navin(The University of Texas MD Anderson Cancer Center), Elinor J. Sawyer(King's College London), P. Andrew Futreal(Wellcome Sanger Institute), Serena Nik‐Zainal(University of Cambridge), Ritse M. Mann(Radboud University Nijmegen), Frederieke van Duijnhoven(Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital), Eveline M. A. Bleiker(Cancer Clinic), Helen Davies(German Cancer Research Center), Esther H. Lips(Oncode Institute), Deborah Collyar(Advocates for Youth), Marja van Oirsouw(Borstkankervereniging Nederland), Sena Alaeikhanehshir(Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital), Hilary Stobart, Renée Schmitz(The Netherlands Cancer Institute), Rosalie Griffioen(The Netherlands Cancer Institute), Valesca P. Retèl(The Netherlands Cancer Institute), E. Shelley Hwang(University of Bern), C. M. T. Sondermeijer(The Netherlands Cancer Institute), Marjanka K. Schmidt(University of Cambridge), Donna Pinto, Nina Bijker(Amsterdam University Medical Centers)
Cited by 1
Related Papers
Mutations of the BRAF gene in human cancer
|Nature|2002|10.7k
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
The cancer genome
|Nature|2009|3.5k
Patterns of somatic mutation in human cancer genomes
|Nature|2007|3.1k